In the past year, China, India, and Thailand each announced ambitious national programs to provide free anti-HIV drugs to people who need them most. Pharmaceutical companies in all three countries have followed Brazil's lead in producing generic versions of brand-name drugs, at a fraction of the cost. Now comes the hard part: figuring out how best to use the drugs.
No takes yet. Share an insight, caveat, or question.
Jon Cohen (2004) studied this question.